Canakinumab Subcutaneous and Zembrace SymTouch
Determining the interaction of Canakinumab Subcutaneous and Zembrace SymTouch and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: sumatriptan
Brand name: Imitrex, Imitrex STATdose, SUMAtriptan Succinate Syringe, Sumavel DosePro, Zembrace SymTouch, Alsuma, Imitrex Statdose Refill, ONZETRA Xsail, Imitrex<, Tosymra, Zecuity
Synonyms: Zembrace SymTouch (injection), Zembrace Symtouch
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Zembrace SymTouch injection
- Canakinumab Subcutaneous-Zemdri
- Canakinumab Subcutaneous-Zemplar
- Canakinumab Subcutaneous-Zemplar (Paricalcitol Capsules)
- Canakinumab Subcutaneous-Zemplar (Paricalcitol Injection)
- Canakinumab Subcutaneous-Zemplar Injection
- Zembrace SymTouch-Canasa
- Zembrace SymTouch-Canasa Pac rectal
- Zembrace SymTouch-Canasa rectal
- Zembrace SymTouch-Cancidas
- Zembrace SymTouch-Candesartan
- Zembrace SymTouch-Candesartan and Hydrochlorothiazide